Kamal Adawi

Insider Reports History

Location
C/O Exagen Inc., 1261 Liberty Way, Suite C, Vista, CA
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamal Adawi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. CFO and Corporate Secretary Common Stock 244K $466K $1.91 Mar 4, 2024 Direct
FATE THERAPEUTICS INC Chief Financial Officer Common Stock 75K $94.5K $1.26 Oct 20, 2025 Direct
FATE THERAPEUTICS INC Chief Financial Officer Stock Option (Right to Buy) 375K Oct 20, 2025 Direct

Insider Reports Filed by Kamal Adawi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FATE FATE THERAPEUTICS INC Oct 20, 2025 2 $0 4 Oct 21, 2025 Chief Financial Officer
FATE FATE THERAPEUTICS INC Oct 20, 2025 0 $0 3 Oct 21, 2025 Chief Financial Officer
XGN EXAGEN INC. Mar 4, 2024 2 -$24.4K 4 Mar 6, 2024 CFO and Corporate Secretary
XGN EXAGEN INC. Feb 20, 2024 1 $0 4 Feb 22, 2024 CFO and Corporate Secretary
XGN EXAGEN INC. Feb 6, 2024 1 -$13.1K 4 Feb 8, 2024 CFO and Corporate Secretary
XGN EXAGEN INC. Mar 2, 2023 1 -$8.43K 4 Mar 3, 2023 CFO and Corporate Secretary
XGN EXAGEN INC. Feb 27, 2023 1 $0 4 Mar 1, 2023 CFO and Corporate Secretary
XGN EXAGEN INC. Feb 8, 2023 1 -$15.7K 4 Feb 10, 2023 CFO and Corporate Secretary
XGN EXAGEN INC. Mar 1, 2022 1 -$23.1K 4 Mar 2, 2022 CFO and Corporate Secretary
XGN EXAGEN INC. Feb 4, 2022 1 $0 4 Feb 8, 2022 CFO and Corporate Secretary